We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
138 hedge funds and large institutions have $780M invested in Madrigal Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more call options, than puts
Call options by funds: $20.5M | Put options by funds: $11.2M
9% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 22
5% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 40
1% less funds holding
Funds holding: 140 → 138 (-2)
1.48% less ownership
Funds ownership: 71.69% → 70.21% (-1.5%)
35% less capital invested
Capital invested by funds: $1.2B → $780M (-$418M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
138
Holders Change
-2
Holders Change %
-1.43%
% of All Funds
2.32%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
24
Increased
42
Reduced
40
Closed
22
Calls
$20.5M
Puts
$11.2M
Net Calls
+$9.27M
Net Calls Change
+$15.7M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$13.4M |
| 2 |
AC
Armistice Capital
New York
|
+$8.97M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$8.75M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$8.09M |
| 5 |
PA
Perceptive Advisors
New York
|
+$6.56M |
